Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications

Bibliography

• CHOBANIAN AV BAKRIS GL, HR et al.: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA (2003) 289(19):2560–2572.
   Google Scholar
• KOSTIS JB, SHELTON B, GOSSELIN G et al.: Adverse effects of enalapril in the studies of left ventricular dysfunction (SOLVD). Am. Heart J. (1996) 131(2):350–355.
   PubMed Web of Science ®Google Scholar
• KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE: K/DOQI Clinical Practice Guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am. J. Kidney Dis. (2004) 43(5 Suppl. 1):S1.
   Google Scholar
• ISRAILI ZH, HALL WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann. Intern. Med. (1992) 117(3):234–242.
   PubMed Web of Science ®Google Scholar
• SABROE RA, BLACK AK: Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br. J. Dermatol (1997) 136(2):153–158.
   PubMed Web of Science ®Google Scholar
• DAUGIRDAS JT, ING TS:-use reactions during hemodialysis: a definition of subtypes. Kidney Int. (1988) 24:S37–S43.
   Google Scholar
• JASPARD E, WEI L, ALHENC-GELAS F: Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II) studies with bradykinin and other natural peptides./ Biol. Chem. (1993) 268:9496–9503.
   PubMed Web of Science ®Google Scholar
• JASPARD E, ALHENC-GELAS F: Catalytic properties of the two active sites of angiotensin I-converting enzyme on the cell surface. Biochem. Biophys. Res. Commun. (1995) 211:528–534.
   PubMed Web of Science ®Google Scholar
• BUNNING P, HOLMQUIST B, RIORDAN JF: Substrate specificity and kinetic characteristics of angiotensin-converting enzyme. Biochemistry (1983) 22:103–110.
   PubMed Web of Science ®Google Scholar
• DECARIE A, RAYMOND P, GERVAIS N, COUTURE R, ADAM A: Serum interspecies differences in metabolic of bradykinin and [des-Arg9]BK: influence of enalaprilat.. J. Physiol Heart Circ. Physiol (1996) 270:H1340–H1347.
   Google Scholar
• ERDOS EG, SKIDGEL RA: of bradykinin by peptidases in health and disease. In: Handbook of Immunopharmacology: The Kinin System. Farmer SG (Ed.), London (1997):111–141.
   Google Scholar
• BLAIS C Jr, MARC-AURELE J, SIMMONS WH: Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides (1999) 20:412–430.
   Web of Science ®Google Scholar
• •Review of in vitro metabolism of des-Arg9-bradykinin in patients with anaphylactoid reactions.
   Google Scholar
• BLAIS C Jr, COUTURE R, DRAPEAU G, COLMAN RW, ADAM A: Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat. Arthritis Rheum. (1997) 40:1327–1333.
   PubMed Web of Science ®Google Scholar
• MARCEAU F: Kinin B] receptors: a review. immunopharmaca (1995) 30:1–26.
   PubMed Web of Science ®Google Scholar
• MARCEAU F, HESS JF, DR: The B] receptors for kinins. Pharmacol Rev. (1998) 50:357–386.
   PubMed Web of Science ®Google Scholar
• GANTEN D, MURLOW PJ: Handbook of Experimental Pharmacology., Springer Verlag, Berlin (1990):377–481.
   Google Scholar
• LINZ W, WIEMER G, GOHLKE P, UNGER T, SCHOLKENS BA: Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. (1995) 47:25–49.
   PubMed Web of Science ®Google Scholar
• UNGER T, GOHLKE P: Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovasc. Res. (1994) 28:146–158.
   PubMed Web of Science ®Google Scholar
• CYR M, HUME HA, CHAMPAGNE M, SWEENEY JD et al.: Anomaly of the des-Arg9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusions: a preliminary study. Transfusion (1999) 39:1084–1088.
   PubMed Web of Science ®Google Scholar
• ADAM A. CUGNO M, MOLINARO G, PEREZ M, LEPAGE Y, AGOSTONI A: Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet (2002) 359(9323):2088–2089.
   PubMed Web of Science ®Google Scholar
• •This paper shows the association between ACEI-AE and low APP activity in a group of patients on ACEI.
   Google Scholar
• NIKPOOR B, MOLINARO G, ADAM A, ROULEAU G: The genetic basis of the acute side effects to the ACE inhibitor drugs. Annual Meeting of the International Society of Pharmacogenomics, Los Angles, USA (2003).
   Google Scholar
• ZEE RY, RAO VS, PASTER RZ, SWEET CS, LINDPAINTNER K: Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis. Hypertension (1998) 31(4):925–958.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI T, YAMAGUCHI E, FURUYA K, KAWAKAMI Y: The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage. Resp. Med. (2001) 95(2):130–135.
   PubMed Web of Science ®Google Scholar
• OKUMURA H, NISHIMURA E, KARIYA S: No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients. [Japanese, English abstract]. Yakugaku Zasshi -Journal of the Pharmaceutical Society of Japan (2001) 121(3):253–257.
   PubMed Web of Science ®Google Scholar
• MUKAE S, AOKI S, ITOH S, IWATA T, UEDA H, KATAGIRI T: Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension (2000) 36(1):127–131.
   PubMed Web of Science ®Google Scholar
• LEE YJ, TSAI JC: Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism (2001) 50(11):1346–1350.
   PubMed Web of Science ®Google Scholar
• CARDON LR, BELL JI: Association study designs for complex diseases. Nat. Rev. Genet. (2001) 2:91–99.
   PubMed Web of Science ®Google Scholar
• TABOR HK, RISCH NJ, MYERS RM: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. (2002) 3:391–397.
   PubMed Web of Science ®Google Scholar
• ••The last two papers review advantages anddisadvantages of association studies versus linkage-based studies in genetics.
   Google Scholar
• FAVIS R, DAY JP, GERRY NP, PHELA C, NAROD S, BARANY F: Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat. Biotechnol (2000) 18(5):561–564.
   PubMed Web of Science ®Google Scholar